Simple. Reliable. Robust. A biomarker with growing clinical applications to drive change in reproductive health.
Many studies have demonstrated that AMH can be used in evaluating a number of clinical conditions, including infertility treatment, menopause, ovarian dysfunction (such as polycystic ovary syndrome), and gonadotoxic cancer treatment or ovarian surgery, and allowing greater individualization of treatment protocols1.
1Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. American Journal of Obstetrics and Gynecology. August 2017